John L. Reagan

Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells

Gudrun Ratzinger, J Baggers, Maria A. de Cos et al. · The Journal of Immunology · 2004 · 169 citations · Full text

Life Sciences, Immunology, Cellular Immunology +16

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83

Brigitte Sénéchal, Adam Boruchov, John L. Reagan et al. · Blood · 2004 · 151 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

Gudrun Ratzinger, John L. Reagan, Glenn Heller et al. · Blood · 2003 · 133 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Bortezomib in combination with infusional dose‐adjusted <scp>EPOCH</scp> for the treatment of plasmablastic lymphoma

Jorge J. Castillo, John L. Reagan, William M. Sikov et al. · British Journal of Haematology · 2015 · 79 citations · Full text

Medicine, Hematology, Oncology +16

Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles

Mandy Pereira, Neha P. Raukar, John L. Reagan et al. · Journal of Cellular Physiology · 2019 · 57 citations · Full text

Life Sciences, Neurology, Neuroscience +17